CAR T-cell | International Myeloma Foundation

PFS-LA collage

Week in Review

September 7

The First In-Person Patient & Family Seminar in L.A. in 3 Years: A Huge Success

What are the side effects and difficulties with new myeloma immune therapies?

August 17

What are the side effects and difficulties with new myeloma immune therapies?

Closeup of scientist taking blood sample in lab

Clinical Trials and Treatments

August 10

Is It Time to Bring the CAR Home Early?

CAR-T therapy in multiple myeloma

Myeloma University

July 18

Myeloma University | The Patient Journey and CAR-T Therapy Management in Multiple Myeloma

EHA2023 Dr. Nikhil Munshi on CARTITUDE-1

July 7

CARTITUDE-1: Final results of Ciltacabtagene Autoleucel in heavily pretreated relapsed/refractory multiple myeloma

2023 IMWG Summit

Week in Review

June 21

2023 Mid-Year Science Update: Entering a New Era of Myeloma Care

EHA23 Bal BMS

June 20

GPRC5D-Targeted CAR T-Cell Therapy for RRMM: Phase 1 Study Outcomes of BMS-986393 (CC-95266)

Dr. Krina Patel discusses the results of the KarMMA-3 study

June 19

IDE-CEL vs Standard Regimens for High-Risk Multiple Myeloma: KARMMA-3 Analysis

ASCO 23 Dr. Mohty MagnetisMM-3

June 13

Elranatamab: Extended Follow-up & Biweekly Admin for RRMM | MagnetisMM-3 Study

What are the differences between CAR T-cell therapy and bispecific antibodies?

April 13

What are the differences between CAR T-cell therapy and bispecific antibodies?

seniors laughing at yoga class

Week in Review

March 30

Can Positive Thoughts Prevent Cancer Growth?

PFS Boca Raton

Week in Review

March 23

Patient & Family Seminar in Boca Raton: A Successful In-Person Reunion

Subscribe to CAR T-cell

Give Where Most Needed